and Joshua Cohen are the co-founders and co-CEOs of Amylyx Pharmaceuticals. Amylyx Pharmaceuticals will take its ALS drug Relyvrio off the market in the U.S. and Canada, ending a multi-year saga for patients with the rare neurodegenerative disease. Relyvrio was approved by the Food and Drug…
#joshuacohen #als #amylyx #justinklee
Continue reading...